capital-raising
Growth capital is money — usually minority equity, sometimes delayed-draw debt — intended to fund expansion rather than to buy out owners. The company is already operating; the capital is meant to scale it.
Growth capital is defined by purpose. It is not a rescue, and it is not (usually) a change of control. Typical uses: new geographies, product lines, bolt-on M&A, working capital for a step-up in scale. Invest Europe’s universe treats growth as a distinct strategy from buyout and venture; the securities are often preferred shares in a minority growth equity deal.
Venture capital can also be “growth” in the English sense. Practitioners still separate early-stage VC (product and market risk) from growth capital (execution and scale risk in a company that already has customers).
Investors underwrite a business valuation on today’s earnings plus a growth case they will not fully pay for in cash — which is why dilution, liquidation preference and sometimes a modest earnout-like ratchet appear. IPEV guidelines still want a fair-value view of the instrument at later reporting dates.
A profitable SaaS company raises €10m of growth capital at €40m pre-money to fund a U.S. sales team. Owners keep control. The investor takes a board seat, 1× preference, and information rights. This is not an LBO. It is also not seed.
Owners use growth capital when they want the factory or the market, not an exit tomorrow. Funds use it when they want upside without paying a control premium. Tension appears when the “minority” investor’s protective provisions amount to control on every real decision.
Calling a majority recap “growth.” Using growth capital to plug a cash hole that quality of earnings would have shown. Promising a five-year hold to an investor whose fund life does not allow it.
Growth capital does not make the market bigger. It also does not replace operational capability.
Growth capital processes fail when the growth case is a slide and the historicals are a mess. Structure the company first — then raise against a valuation that a growth equity investor can take to IC.